Linda L. Nardone, Ph.D., RAC

Chief Operating Officer and Executive Vice President

Dr. Nardone holds the offices of Chief Operating Officer and Executive Vice President of Encorium Group, Inc. She has 23 years of experience in big pharmaceutical and start-up biotechnology companies. This includes general management experience and drug development responsibilities across many aspects of drug and device development, viz., Regulatory Affairs, Clinical Affairs, Quality, Product Development and Project Management. Dr. Nardone’s regulatory experience spans investigational and marketed products, small and large molecules, drug, biologics and devices, proprietary and generic products, and a wide range of dosage forms (tablets, parenterals, injectables, creams and ointments).

Dr. Nardone received her Ph.D. and M.S. in physiology from Pennsylvania State University and her B.S. from Fairleigh Dickinson University. She enjoyed an academic career at Yale University School of Medicine and New York Medical College prior to joining the pharmaceutical industry. She has authored 35 publications and was the editor/author of the first edition of a textbook for regulatory affairs; “Fundamentals of Regulatory Affairs.”

Dr. Nardone brings to Encorium a breadth of corporate experience and experience with ex-US pharmaceutical entities. She has been a member of corporate management in 3 start-up companies and has been integral to venture capital financing, Initial Public Offering (IPO), and accessing government funding. Dr. Nardone has also been an employee of global companies whose headquarters were European-based (Pharmacia, Nycomed, Sanofi, and Byk Gulden).